This article is a correction to:
Unfractionated and Low-Molecular-Weight Heparin and the Phosphodiesterase Inhibitors, IBMX and Cilostazol, Block Ex Vivo Equid Herpesvirus Type-1-Induced Platelet Activation
Tracy Stokol
Priscila B. S. Serpa
Muhammad N. Zahid
Marjory B. Brooks
A Corrigendum on
The spelling of Priscila B. D. Serpa is wrong. The correct is Priscila B. S. Serpa (from full name Priscila Beatriz da Silva Serpa). The authors apologize for the mistake. This error does not change the scientific conclusions of the article in any way.
The original article has been updated.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Keywords: equine, EHV-1, thrombin generation, thrombosis, P-selectin, flow cytometry, horse
Citation: Stokol T, Serpa PBS, Zahid MN and Brooks MB (2017) Corrigendum: Unfractionated and Low-Molecular-Weight Heparin and the Phosphodiesterase Inhibitors, IBMX and Cilostazol, Block Ex Vivo Equid Herpesvirus Type-1-Induced Platelet Activation. Front. Vet. Sci. 4:10. doi: 10.3389/fvets.2017.00010
Received: 19 January 2017; Accepted: 24 January 2017;
Published: 10 February 2017
Edited and Reviewed by: Peter James O’Brien, University College Dublin, Ireland
Copyright: © 2017 Stokol, Serpa, Zahid and Brooks. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Tracy Stokol, tracy.stokol@cornell.edu